THIS CHANGES EVERYTHING

The BIOFIRE® SPOTFIRE® 
Respiratory Solution

5 Targets or 15 Targets—You Decide 

bioMérieux is pleased to announce a revolutionary portfolio of versatile, lab-grade respiratory PCR tests, the targeted BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini and expanded BIOFIRE® SPOTFIRE® Respiratory (R) Panel, which give clinicians flexible syndromic options as they care for a variety of patients. These tests run on a new, fast, easy-to-use BIOFIRE® SPOTFIRE® System. 


©2023 bioMérieux, Inc. • BIOMÉRIEUX, the BIOMÉRIEUX logo, PIONEERING DIAGNOSTICS, BIOFIRE, and FILMARRAY are used pending and/or registered trademarks belonging to bioMérieux, or one of its subsidiaries, or one of its companies • Patents • 515 Colorow Drive, Salt Lake City, UT 84108 • Tel: (800) 634-7656

bioMérieux S.A. • 69280 Marcy l’Etoile • France • www.biomerieux-usa.com

Privacy Policy

Don't Guess. Know.

Please fill out the form below to receive updates on the new SPOTFIRE solution:

BIOFIRE SPOTFIRE System

By clicking the button below, you have read and agree to the Privacy Policy and agree to receive emails from bioMérieux. You can unsubscribe at any time.

* Required Fields

The SPOTFIRE System is designed to run the SPOTFIRE R Panels.

  • Requires minimal benchtop space and can be scaled vertically, up to four modules, enabling customizable throughput
  • Module random access allows the ability to run up to 4 tests at the same time
  • Easy to use with an intuitive system interface and streamlined workflow
  • Seamlessly connects with point-of-care data management systems and other compatible systems and software

BIOFIRE SPOTFIRE Respiratory (R) Panel Mini

1 PCR Test. 5 Targets. ~15 Minutes.

SPOTFIRE Respiratory Panel Mini Menu


Sample Type: Nasopharyngeal swab in viral transport media
Hands-on time: 1-2 minutes 
Overall Performance:1 PPA: 98.7% NPA: 98.4% 
SARS-CoV-2 Performance:1 PPA: 97.3%, NPA: 99.4%

VIRUSES:

  • Coronavirus SARS-CoV-2
  • Human rhinovirus
  • Influenza A virus
  • Influenza B virus
  • Respiratory syncytial virus

The typical symptoms of a respiratory infection can be caused by many viruses and bacteria. Remove the guesswork with syndromic testing. 

Learn more about our point-of-care solutions.

white-array

1. Calculated based on an 8-hour shift.

FDA CLEARED | CLIA WAIVED

Get a Quote
Get a Quote

BIOFIRE SPOTFIRE Respiratory (R) Panel

1 PCR Test. 15 Targets. ~15 Minutes.

SPOTFIRE Respiratory Panel Menu



Sample Type: Nasopharyngeal swab in viral transport media
Hands-on time: 1-2 minutes 
Overall Performance:1 PPA: 98.5% NPA: 99.1% 
SARS-CoV-2 Performance:1 PPA: 97.3%, NPA: 99.4%

VIRUSES:

  • Adenovirus
  • Coronavirus SARS-CoV-2
  • Coronavirus (seasonal)
  • Human metapneumovirus
  • Human rhinovirus/enterovirus
  • Influenza A virus
    • Influenza A virus A/H1-2009
    • Influenza A virus A/H3
  • Influenza B virus
  • Parainfluenza virus
  • Respiratory syncytial virus

BACTERIA:

  • Bordetella parapertussis
  • Bordetella pertussis
  • Chlamydia pneumoniae
  • Mycoplasma pneumoniae

FDA CLEARED | CLIA WAIVED

Get a Quote

TARGETED SYNDROMIC TESTING

EXPANDED SYNDROMIC TESTING

FDA CLEARED | CLIA WAIVED

FDA CLEARED | CLIA WAIVED